A Multicenter Cancer Biospecimen Collection Study
Recruiting
Observational Study
Cancer of Head and Neck
Lung Cancer, Nonsmall Cell
Small-cell Lung Cancer
Urothelial Carcinoma
Gastroesophageal Junction Adenocarcinoma
Cervical Cancer
Esophageal Squamous Cell Carcinoma
Triple Negative Breast Cancer
Hepatocellular Carcinoma
Renal Cell Carcinoma
Colorectal Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,650 (estimated)
- Sponsor
- Cofactor Genomics, Inc. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study will collect de-identified tumor samples, with correlated clinical/demographic data and tissue histology, from patients selected or scheduled for pre-treatment tumor biopsy or who have had a recent pre-treatment tumor biopsy. These specimens and clinical data may be used in subsequent studies for the development and validation of a diagnostic test.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Subject must have a disease of interest. Specifically, subject must have one of:
1. head and neck squamous cell carcinoma (HNSCC)
2. non-small-cell lung cancer (NSCLC)
3. small cell lung cancer (SCLC)
4. urothelial carcinoma (UCC)
5. gastric or gastroesophagea…
Contacts